Test Price
2,800 AED✅ Home Collection Available
KISS1 Gene Hypogonadotropic Hypogonadism Genetic Test in UAE | AED 2800 | 2026 DHA Guidelines
تحليل جين KISS1 لنقص الغدد التناسلية الناقص الموجهة للغدد التناسلية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يُجرى تحليل جين KISS1 بتقنية التسلسل الجيني من الجيل التالي (NGS) للكشف عن الطفرات المسببة لنقص الغدد التناسلية الناقص الموجهة للغدد التناسلية، مع ضمان دقة تشخيصية تصل إلى 99.9% وفق معايير ISO 9001:2015 وترخيص هيئة الصحة بدبي رقم 9834453.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed physicians for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Why This Test Matters – Precision Genomic Diagnosis for Reproductive Health
يُعد هذا التحليل الجيني المتطور ضروريًا للتشخيص الدقيق — This advanced NGS test comprehensively sequences the entire coding region of the KISS1 gene to identify pathogenic variants linked to hypogonadotropic hypogonadism, a condition causing absent or delayed puberty and infertility. It provides a definitive molecular diagnosis, empowering personalized treatment with gonadotropin therapy or assisted reproduction.
| Feature | Our KISS1 NGS Test | Standard Hormonal Assay |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene analysis | Immunoassay for FSH/LH/estradiol |
| Coverage | >99.9% of coding region + exon–intron boundaries | Circulating hormone levels (functional snapshot) |
| Turnaround Time | 3‑4 Weeks | 1‑2 Days |
| Clinical Utility | Definitive genetic diagnosis, familial cascade testing, personalized therapy planning | Indirect biochemical assessment; often requires repeated testing |
Consultant Insight & Safety Protocol
“As a reproductive endocrinologist, I understand that searching for a cause of delayed puberty or infertility can be emotionally taxing. This test provides molecular clarity, but results must be interpreted within the full clinical picture—no single gene defines your future. Please never stop prescribed hormonal therapy without a doctor’s oversight.”
— Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Do not discontinue any prescribed medication without consulting your doctor.
Exclusion Criteria & Red Flags
- Active systemic infection or febrile illness precluding blood draw.
- Individuals on anticoagulants that cannot be briefly paused under medical supervision.
- ER Red Flags: sudden severe headache, acute vision loss or visual field cut, unexplained hypotension or loss of consciousness—seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What symptoms suggest a need for KISS1 gene testing?
ما الأعراض التي تستدعي إجراء تحليل جين KISS1؟
Direct Answer: Persistent delayed puberty, absent menstruation, infertility of pituitary origin, anosmia, or a family history of hypogonadotropic hypogonadism are key indicators for testing.
Clinical scenarios include isolated GnRH deficiency, normosmic idiopathic hypogonadotropic hypogonadism, or combined pituitary hormone deficiencies. The test uncovers variants in KISS1 that disrupt pubertal onset and reproductive function, helping differentiate from constitutional delay or structural anomalies.
2. How is the sample collected and what preparation is required?
كيف يتم جمع العينة وما التحضيرات اللازمة؟
Direct Answer: A single blood draw (3‑5 mL in EDTA tube) or dried blood spot on FTA card requires no fasting; a prior genetic counseling session documents the family pedigree.
Our VIP mobile phlebotomy team collects from home/office using ISO‑certified cold‑chain transport. Pre‑test information should include clinical history of pubertal development, previous hormonal assays, and any relevant family history. Discontinue anticoagulants only under medical advice 48 hours before sample collection.
3. What do the results mean and who interprets them?
ماذا تعني النتائج ومن يفسرها؟
Direct Answer: The report identifies pathogenic/likely pathogenic variants, variants of uncertain significance, or no relevant variant, and is interpreted by a board‑certified clinical geneticist.
A positive result confirms the genetic form and enables targeted family screening. Variants of uncertain significance may require periodic re‑analysis. Post‑ telephonic guidance with our DHA‑licensed reproductive endocrinologist ensures clear understanding and connection to appropriate care. All data is protected under UAE PDPL and Federal Decree‑Law No. 41/2024, Art. 87.
Regulatory Compliance & Accreditation: This service is delivered under DHA Facility License 9834453 and adheres to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All testing complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), the CDS Law 2026 for minors, and PDPL data privacy standards. LOINC Code 78824-5. ICD‑10‑CM: E23.0, E29.1, Z15.89.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians